Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding

Table 2 Procedures in endoscopic variceal obturation and percutaneous transhepatic variceal embolization groups

	EVO(n = 45)	PTVE(n = 32)	P value
Status of GV			0.290
Disappeared	17/45	16/32
Collapsed	16/45	12/32
Remained	12/45	4/32
Amount of cyanoacrylate (mL)	3.03 ± 1.04	6.69 ± 2.92	0.000
Rebleeding	17/45	4/32	0.028
Rebleeding from GV	13/45	2/32	0.029
Rebleeding from other sources	4/45	2/32	1.000
EV bleeding	2	1	1.000
PHG	1	1	1.000
Unknown	1	0	1.000
Death during follow-up	8/45	4/32	0.751
Causes of death
Progressive Liver failure	5/45	3/32	1.000
Rebleeding	2/45	1/32	1.000
HCC	1/45	0/32	1.000

EV: Esophageal varices; GV: Gastric varices; EVO: Endoscopic variceal obturation; PHG: Portal hypertensive gastropathy; HCC: Hepatocellular carcinoma; PTVE: Percutaneous transhepatic variceal embolization.